Healthcare Jan 25, 2022 04:34 PM (GMT+8) · EqualOcean
Yiouda health learned on the 25th that a few days ago, yikelai biology announced that the company invested in and established Shanghai Guanling Gene Technology Co., Ltd. (hereinafter referred to as "Guanling gene" or "company"), focusing on the revolutionary technology development from the genetic level and the development of first in class health monitoring means focusing on delaying human aging and diseases caused by aging. Age watching gene is committed to focusing on health and longevity and giving birth to revolutionary original technology from the genetic level. The company aims to combine enzyme chemical markers with gene sequencing technology to develop new biomarkers to realize dynamic monitoring and early warning of the process of physiological aging and the evolution from natural aging to degenerative diseases. Through forward-looking layout, the company has completed the independent production of key enzymes through synthetic biology technology, created a closed loop of the whole process, and formed an industrial moat. Synthetic biology, as the key of "intelligent creation", is being accelerated and applied to all fields of society. This time, Ecole biology and age watching gene have jointly driven a new generation of health monitoring methods through synthetic biology technology, incubated the industrialization of original life science and technology achievements, enabled human health and longevity with science and technology, and provided new ideas for human science to explore the path of health and longevity.

This text is a result of machine translation.